Cidara Therapeutics Inc (NASDAQ:CDTX)
| 2.11 Delayed Data As of Jun 15 |  +0.01 / +0.48%Today’s Change | 1.76 Today|||52-Week Range 4.45 | +5.50% Year-to-Date |
Latest CDTX News | Press Releases
No recent news for Cidara Therapeutics Inc.
Today’s Trading
| Previous close | 2.10 |
| Today’s open | 2.12 |
| Day’s range | 2.04 - 2.12 |
| Volume | 9,348 |
| Average volume (3 months) | 811,109 |
| Market cap | $104.8M |
Data as of 3:59pm ET, 06/15/2021
Growth & Valuation
| Earnings growth (last year) | -27.56% |
| Earnings growth (this year) | +26.00% |
| Earnings growth (next 5 years) | +75.40% |
| Revenue growth (last year) | -42.30% |
| P/E ratio | NM |
| Price/Sales | 6.89 |
| Price/Book | 9.09 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LFVNLifeVantage Corp | -0.14 | -1.69% |
| ISRIsoRay Inc | -0.02 | -2.92% |
| ---- | ||
| EVOKEvoke Pharma Inc | -0.07 | -5.28% |
Data as of 4:00pm ET, 06/15/2021
Financials
| Next reporting date | August 11, 2021 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $12.1M |
| Annual profit (last year) | -$74.9M |
| Net profit margin | -620.48% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
